NEW YORK (GenomeWeb) – Thermo Fisher Scientific said on Thursday it has reached a deal with NewLab Engineering for the exclusive global distribution rights to the Card Processing Automation technology for DNA-based human identification.

Thermo Fisher will be the sole distributor and servicing agent of NewLab's CPA300 and CPA200 card processing instruments. CPA technology is used by forensic, paternity, and research laboratories to prepare DNA samples for human identification.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.